Navigation Links
New licensing agreement to maximize AIDS drug development

Longtime collaborators CONRAD and the Biosyn Division of Cellegy Pharmaceuticals, Inc. today announced a non-exclusive licensing agreement to research and develop Biosyn-patented microbicides for the prevention of HIV and other sexually transmitted diseases.

The three microbicides covered under the agreement are in various stages of development and work under different mechanisms of action. They include: Savvy, which is currently in Phase III clinical trials in the U.S. and Africa; UC781 which is in expanded Phase II trials in the U.S and Thailand and Cyanovirin-N which is in preclinical testing. Henry Gabelnick, Ph.D., executive director of CONRAD says, "This agreement is great news for everyone interested in developing an effective microbicide. The more partnerships we have like this one, the better our potential is for getting an effective product ready for distribution."

"I am delighted for our two organizations to enter into this agreement. We have collaborated for many years on all aspects of our microbicide development programs, and we have a deep respect for each other's knowledge and expertise. With CONRAD, we feel we have a capable and experienced partner to work with us toward approval of these critically important products," said Anne-Marie Corner, Senior Vice President of Cellegy Pharmaceuticals.Currently, the highest rates of infection in women are in sub-Saharan Africa and rates are increasing in women in South and Southeast Asia.

CONRAD has been involved in the research of nearly every microbicide currently in clinical trials. They are currently managing a second Phase III trial of a microbicide called Ushercell in Uganda and South Africa, Benin, Burkina Faso and two centers in India. The trials will evaluate Ushercell for the prevention of HIV infection among 2,574 adult women at high risk of acquiring HIV. This study will also assess incidence of genital gonorrhea and chlamydia.

CONRAD is a cooperating agen
'"/>

Source:Rational PR


Page: 1 2

Related biology news :

1. Genomatix, AAAS ink agreement
2. A much-needed shot in the arm for HIV vaccine development
3. Clam embryo study shows pollutant mixture adversely affects nerve cell development
4. Zebrafish may hold key to understanding human nerve cell development
5. Scientists identify new model Of NK cell development
6. Influenza vaccine uses insect cells to speed development
7. Liposome finding implies electrical effect on cell development
8. Multi-purpose protein regulates new protein synthesis and immune cell development
9. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
10. Scientists find microRNAs regulate plant development
11. MicroRNA tweaks protein that controls early heart development
Post Your Comments:
(Date:7/2/2008)... Scientists from Hungary, Germany and the U.K. hav...ical compounds similar to the active ingredient in...t in maintaining healthy skin. This finding on "e...eduled for the October 2008 print issue of, The F...kin conditions ranging from acne to dry skin, and ...
(Date:7/2/2008)... COLLEGE STATION, July 2, 2008 -- Two Texas A&M Un...l tool that will help scientists more accurately s...ons, in bacteria. The tool, which allows scientist...re accurate than previous methods because it start...om statistical predictions, they say. The research...
(Date:7/2/2008)... COLUMBUS, Ohio -- When chemists want to produce a...ug -- they often turn to catalysts, molecules that...y specialized catalysts, and finding one in just t...an be difficult. Natural catalysts, such as enzyme...around this problem by shape-shifting to suit the ...
(Date:7/2/2008)... This release is available in Spanish . , Mo...sult of interactions between proteins, which recog...calized on the protein surface. There are many kin...to study from the perspective of structural biolog...raction is brief and occurs through a large sectio...
Breaking Biology News(10 mins):Texas A&M researchers develop tool to study complex clusters of genes 2Texas A&M researchers develop tool to study complex clusters of genes 3Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Scientists reveal the key mechanisms for affinity between transient binding proteins 2South Florida Gynecologic Oncologists Begin Using LUMA 28R 29 Cervical Pre Cancer Imaging Device 13253 1South Florida Gynecologic Oncologists Begin Using LUMA 28R 29 Cervical Pre Cancer Imaging Device 13253 2South Florida Gynecologic Oncologists Begin Using LUMA 28R 29 Cervical Pre Cancer Imaging Device 13253 3Healthy Coffee USA Launches Founders Club 13251 1Healthy Coffee USA Launches Founders Club 13251 2Healthy Coffee USA Launches Founders Club 13251 3Vapotherm CEO Receives Top Business Leadership Award From World Trade Center Institute 13249 1Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 3658 1Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 3658 2Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 3658 3
...s--is the most abundant biological material on Ear...t-based biofuels research. Despite overwhelming in...w plant cells synthesize individual cellulose fibe...tution,s Department of Plant Biology and Stanford ...ons of cellulose fiber formation. The research, pu...
...ical engineering at New Jersey Institute of Techno...m cell researchers, has received two grants that w...ch a step closer to reality. , Arinzeh received...n Spinal Cord Research, a state agency that funds ...ild a laboratory to test if stem cells taken from ...
...second counts. Yet bruises, burns, and other physi...eins and administer lifesaving drugs or solutions....hnology researchers is developing an inexpensive, ...ology to find veins quickly. , "Depth and angle ...s project leader Michael Gray, a research engineer...
... lactic acid is poison, a waste product that build...educed performance and pain. , Some 30 years of re...however, tells a different story: Lactic acid can ...ize it, says exercise physiologist George Brooks, ...endurance training teaches the body to efficiently...
Other Biology News:Formation of cellulose fibers tracked for the first time 2NJIT engineer poised to take stem cell research a step forward 2NJIT engineer poised to take stem cell research a step forward 3Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 2Lactic acid not athlete's poison, but an energy source - if you know how to use it 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 4
(Date:7/2/2008)... Bioniche,s growing line of injectable ...July 2 /- Bioniche Pharma, a leading,...ticals, announced today,the acquisition of Baxter ...ding:, -- ENLON(R) (edrophonium chloride inject...edrophonium chloride, USP and atropine sulfate, US...
(Date:7/2/2008)...re-FirstCall/ -- Bioheart, Inc. (Nasdaq:,BHRT) a b...pment of,autologous (patient-derived) cell therapi...ute heart damage, today announced it has been adde...Investment Group reconstituted its,comprehensive s...008., According to the Russell Investment Group, ...
(Date:7/2/2008)...ureus Pharma, a leading provider of,knowledge mana...fe science,industry, announced today that the Aure...s on October 23rd and 24th., This symposium follo...hich was attended by many of Aureus, pharmaceutica... America. The symposium included presentations,fro...
(Date:7/2/2008)...RNewswire/ -- Research conducted at The,Walter and...ficantly to a,major licensing agreement signed bet...(ASX:BNO) and Germany-based pharmaceutical company...ing Agreement, Merck Serono will seek,to develop n...r autoimmune,conditions. These prospective treatme...
Breaking Biology Technology:Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Bioheart, Inc., Added to Russell Microcap Index 2Aureus Pharma Announces Date of 2008 Annual User Symposium 2MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2
..., a designer and manufacturer of energy management...ng to develop and deploy new technologies and solu...y efficiency improvements. , ,The Technology Trans...mbus-based investment advisory firm Custer Capita...Ohio with offices in Madison and Sussex, Wis., mad...
...t information technology industry, Wisconsin may h...eynoters at this week,s E-Business Best Practices ... months, information technology executives, most n...shy about the changes they would make. But leaders...t cite Jazwiec,s menu of steep income tax cuts and...
...ion would enable Johnson Controls, Inc. , a globa... batteries annually, to expand its automotive afte...countries, the company said. , ,In an arrangement ...g," Johnson Controls, which is developing a next-g...motive battery business of the Italian components ...
...gy that allows researchers to test new drugs on ti... And fortunately for one local company, the federa... of such an endeavor. , ,To improve its technology...firm based here, will receive $91,490 from the Na...dicine at the National Institutes of Health . , ...
Other Biology Technology:Orion Energy completes $5M capital round 2To drive IT, Wisconsin may need entrepreneurial makeover 2To drive IT, Wisconsin may need entrepreneurial makeover 3InvivoSciences receives NIH grant for heart technology 2
Have you bought a Perkin Elmer UltraVIEW system and want to enjoy the sensitivity of using the Andor iXon and iQ software? No problem. Our experienced team can give you that upgrade. You keep your e
The DNA Engine Dyad instrument is the most advanced thermal cycler ever made. Featuring MJ's world-class thermal performance, the Dyad also boasts graphical programming and color display, as well a
Benzonase Nuclease HC, Purity > 90% from Novagen
Chromosomal Grade Agarose from Bio-Rad
Biology Products: